Infliximab as an Effective Second-Line Treatment for IVIG-Resistant Kawasaki Disease Accompanied by Severe Dyslipidemia - Scorecard - MDSpire

Infliximab as an Effective Second-Line Treatment for IVIG-Resistant Kawasaki Disease Accompanied by Severe Dyslipidemia

  • By

  • Yuto Sunaga

  • Yohei Hasebe

  • Masashi Yoshizawa

  • Yosuke Kono

  • Keiichi Koizumi

  • Nobuyuki Katsumata

  • Takako Toda

  • Minako Hoshiai

  • Koji Kobayashi

  • Sho Hokibara

  • Hiroko Oshiro

  • Emi Sawanobori

  • Tomoaki Sano

  • Masanori Ohta

  • Makoto Tsuruta

  • Makoto Nakamura

  • Kazumasa Sato

  • Hiroki Sato

  • Takeshi Inukai

  • June 4, 2026

  • 0 min

Share

Clinical Scorecard: Efficacy of Infliximab as a Secondary Treatment for Kawasaki Disease Resistant to IVIG with Severe Dyslipidemia

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationPatients aged ≥ 1 year with IVIG-resistant Kawasaki Disease.
Care Setting

Key Highlights

  • add_references

Guideline-Based Recommendations

Diagnosis

    Management

    • I
    • n
    • c
    • l
    • u
    • d
    • e
    • c
    • o
    • r
    • t
    • i
    • c
    • o
    • s
    • t
    • e
    • r
    • o
    • i
    • d
    • s
    • a
    • s
    • a
    • s
    • e
    • c
    • o
    • n
    • d
    • -
    • l
    • i
    • n
    • e
    • t
    • h
    • e
    • r
    • a
    • p
    • y
    • o
    • p
    • t
    • i
    • o
    • n
    • .

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Clinical Best Practices

        • rationale

        Related Resources & Content

        Original Source(s)

        Infliximab as an Effective Second-Line Treatment for IVIG-Resistant Kawasaki Disease Accompanied by Severe Dyslipidemia

        • by Yuto Sunaga, Yohei Hasebe, Masashi Yoshizawa, Yosuke Kono, Keiichi Koizumi, Nobuyuki Katsumata, Takako Toda, Minako Hoshiai, Koji Kobayashi, Sho Hokibara, Hiroko Oshiro, Emi Sawanobori, Tomoaki Sano, Masanori Ohta, Makoto Tsuruta, Makoto Nakamura, Kazumasa Sato, Hiroki Sato, Takeshi Inukai

        • June 4, 2026

        Related Content

        Editorial: Understanding oral health challenges in pediatric and adult cancer care

        A connectome-based neural correlate of pediatric ADHD hyperactivity–impulsivity symptoms

        Case Report: Clinical management of genital, perineal, and perianal venous malformation in a five-year-old boy: therapeutic decision-making and review of current literature